MUMBAI:

India said on Sunday it was considering granting an emergency authorisation for a COVID-19 vaccine, particularly for the elderly and people in high-risk workplaces, as the country’s number of reported infections passed 4.75 million.ndia, which has consistently reported over 1,000 COVID-19 deaths daily this month, has now recorded 78,586 fatalities from the disease. It lags only the United States globally in overall number of infections, but it has been adding more daily cases than the United States since mid-August.

“India is considering emergency authorisation of a COVID-19 vaccination,” said Union Health and Family Welfare Minister Harsh Vardhan. “If there is a consensus we may go ahead with it, especially in the case of senior citizens and people working in high-risk settings.”

Vardhan said the timeline on Phase III trials could be shortened by giving emergency authorisation, but stressed no corners would be cut in clinical trials and that a vaccine would only be made available when the government could ensure its safety and efficacy.

He said no date has been set for a vaccine launch, but added results of trials should be clear by the first quarter of 2021.

“A vaccine expert group has been established recently by the government to look into various issues related to the delivery of vaccines to vulnerable populations,”

The comments came as the Indian health ministry reported 94,372 new COVID-19 cases and 1,114 deaths on Sunday.

"While no date has been fixed for the vaccine launch, it may be ready by the first quarter of 2021," he said.The National Expert Group on Vaccine Administration for Covid-19 is drawing up a detailed strategy on how to immunise the majority of the population, he said during the 'Sunday Samvad' programme where he interacted with his social media followers and answered their questions.
 

"Issues like vaccine security, cost, equity, cold-chain requirements, production timelines, etc, are also being discussed intensely," he said. He assured the vaccine would be first made available to those who need it the most, irrespective of their paying capacity.
Harsh Vardhan also said he would be happy to take the first dosage of the vaccine if some people have a trust deficit.

His statement came in the wake of an incident in the UK where one of the participants in the ongoing trial of the University of Oxford's vaccine candidate developed a severe complication right after being administered its dose.

The minister also informed about vaccine candidates and their development in India.

"Department of Bio-Technology (DBT), as well as the Indian Council of Medical Research (ICMR), have been pro-active in responding to the emerging situation to support the advancement of vaccine candidates. India is actively partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), and trials at different phases are ongoing with respect to several vaccines in Indian laboratories (private ..

The government’s efforts to kickstart the economy, which saw a 23.9% contraction in the April-June quarter, have been hamstrung by the surge in cases.

The western state of Maharashtra, the nation’s richest and a key industrial hub, has recorded more than 1.03 million infections.

In a briefing on Sunday, the state’s chief minister, Uddhav Thackeray, urged residents to wear masks, maintain social distancing and avoid crowds, amid growing fatigue over a drawn-out lockdown that has made many people lax about precautions.

The state has been easing various restrictions gradually and it recently allowed hotels to operate under certain conditions, though many businesses remain shut. Thackeray said Maharashtra was considering reopening dine-in restaurants and gyms following appeals from business owners.